✦ LIBER ✦

Iron, ferritin, hepatitis B surface and core antigens in the livers of chinese patients with hepatocellular carcinoma

✍ Scribed by Xin-Da Zhou; Louis Detolla; R. Philip Custer; W. Thomas London

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 769 KB
Volume: 59
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19870415)59:8<1430::aid-cncr2820590808>3.0.co;2-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recurrence of hepatocellular carcinoma a

Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen–positive patients after liver transplantation

✍ Sammy Saab; Melina Yeganeh; Kelvin Nguyen; Francisco Durazo; Steven Han; Hasan Y 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

Hepatitis B virus (HBV) reinfection and recurrence of hepatocellular carcinoma (HCC) after orthotopic liver transplantation (OLT) are associated with increased graft failure and reduced patient survival. We evaluated the effects of both HCC recurrence and HBV reinfection on the long-term survival of

Association of concurrent hepatitis B su

Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection

✍ Ji Sun Jang; Hyoung Su Kim; Ha Jung Kim; Woon Geon Shin; Kyung Ho Kim; Jin Heon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

## Abstract Antibody to hepatitis B surface antigen (HBsAg) (anti‐HBs) can exist in patients with chronic hepatitis B virus (HBV) infection. To date, little is known about the association of concurrent HBsAg and anti‐HBs (concurrent HBsAg/ anti‐HBs) with hepatocellular carcinoma (HCC). The aim of t

Liver cell dysplasia in association with

Liver cell dysplasia in association with hepatocellular carcinoma, cirrhosis and hepatitis b surface antigen in Hong Kong

✍ Joana C. I. Ho; Piu-Chee Wu; Tak-Kwan Mak 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 French ⚖ 394 KB

## Abstract Liver‐cell dysplasia was identified in 60% of 558 cases of cirrhosis with and without hepatocellular carcinoma (HCC) in Chinese coming to necropsy in Hong Kong from 1963 to 1978. A significant correlation was found between liver‐cell dysplasia and the identification of hepatitis B surfa

Localization of hepatitis B surface and

Localization of hepatitis B surface and core antigens in human hepatocellular carcinoma by immunoperoxidase methods. Replication of complete virions of carcinoma cells

✍ Koyu Suzuki; Toshikazu Uchida; Ryuzo Horiuchi; Toshio Shikata 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 694 KB

The localization of hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) was investigated by an indirect immunoperoxidase method in formalin-fixed, paraffin-embedded liver specimens obtained from 95 Japanese patients with hepatocellular carcinomas. Routine and immune electron microscopic exa

Clearance of hepatitis B surface antigen

Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus

✍ Josephine Simonetti; Lisa Bulkow; Brian J. McMahon; Chriss Homan; Mary Snowball; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

Some individuals who are chronically infected with hepatitis B virus (HBV) eventually lose hepatitis B surface antigen (HBsAg). Hepatocellular carcinoma (HCC) has been demonstrated to occur in a few patients after loss of HBsAg. Neither factors associated with loss of HBsAg nor the incidence of HCC

Comparison between polyclonal and first

Comparison between polyclonal and first and second generation monoclonal radioimmunoassays in the detection of hepatitis B surface antigen in patients with hepatocellular carcinoma

✍ Michael C. Kew; Yumiko Fujita; Hiroshi Takahashi; Ann Coppins; Jack R. Wands 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

Serum from 221 black patients with hepatocellular carcinoma was tested for HBsAg using a polyclonal radioimmunoassay, and first and second generation monoclonal radioimmunoassays designated M1-RIA and M2-RIA. These monoclonal radioimmunoassays have a lower limit of detection of about 55 and 15 pg of